CASP3 and central nervous system cancer: We found no evidence of caspase-3 activation in these cells in response to coibamide A treatment (Fig. 11B), consistent with the pattern of caspase-independent cell death observed in U87-MG glioma cells (Fig. 4B and Fig. S4).